相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Disulfiram Transcends ALDH Inhibitory Activity When Targeting Ovarian Cancer Tumor-Initiating Cells
Michael W. Caminear et al.
FRONTIERS IN ONCOLOGY (2022)
miR-335-5p suppresses gastric cancer progression by targeting MAPK10
Yi Gao et al.
CANCER CELL INTERNATIONAL (2021)
MiR-452-5p promotes colorectal cancer progression by regulating an ERK/MAPK positive feedback loop
Xin Lin et al.
Aging-US (2021)
MiR-452-5p mediates the proliferation, migration and invasion of hepatocellular carcinoma cells via targeting COLEC10
Jianxing Zheng et al.
PERSONALIZED MEDICINE (2021)
miR-335 Restrains the Aggressive Phenotypes of Ovarian Cancer Cells by Inhibiting COL11A1
Yi-Hui Wu et al.
CANCERS (2021)
The hallmarks of ovarian cancer stem cells and niches: Exploring their harmonious interplay in therapy resistance
Takeshi Motohara et al.
SEMINARS IN CANCER BIOLOGY (2021)
miRDB: an online database for prediction of functional microRNA targets
Yuhao Chen et al.
NUCLEIC ACIDS RESEARCH (2020)
Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model
Brittney S. Harrington et al.
CANCERS (2020)
The Role of microRNAs in Epithelial Ovarian Cancer Metastasis
Vu Hong Loan Nguyen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study
Hui Yu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
miRBase: from microRNA sequences to function
Ana Kozomara et al.
NUCLEIC ACIDS RESEARCH (2019)
The biochemical basis of microRNA targeting efficacy
Sean E. McGeary et al.
SCIENCE (2019)
Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data
Weijun Liu et al.
GENOME BIOLOGY (2019)
mirDIP 4.1-integrative database of human microRNA target predictions
Tomas Tokar et al.
NUCLEIC ACIDS RESEARCH (2018)
MiR-335-5p restores cisplatin sensitivity in ovarian cancer cells through targeting BCL2L2
Ruonan Liu et al.
CANCER MEDICINE (2018)
Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals
Wei Zhai et al.
MOLECULAR CANCER (2018)
NFκB Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH+ Cancer Stem-like Cells
Carrie D. House et al.
CANCER RESEARCH (2017)
miR-130a upregulates mTOR pathway by targeting TSC1 and is transactivated by NF-κB in high-grade serous ovarian carcinoma
Yuqiong Wang et al.
CELL DEATH AND DIFFERENTIATION (2017)
MicroRNA-452 promotes stem-like cells of hepatocellular carcinoma by inhibiting sox7 involving wnt/β-catenin signaling pathway
Zhiyun Zheng et al.
ONCOTARGET (2016)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Predicting effective microRNA target sites in mammalian mRNAs
Vikram Agarwal et al.
ELIFE (2015)
miR-335 Represents an Independent Prognostic Marker in Epithelial Ovarian Cancer
Jin Cao et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
Characterization of microRNA expression in serous ovarian carcinoma
Yanhong Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Reduced expression of SOX7 in ovarian cancer: a novel tumor suppressor through the Wnt/β-catenin signaling pathway
Huidi Liu et al.
JOURNAL OF OVARIAN RESEARCH (2014)
Kraken: ultrafast metagenomic sequence classification using exact alignments
Derrick E. Wood et al.
GENOME BIOLOGY (2014)
Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation
Davis J. McCarthy et al.
NUCLEIC ACIDS RESEARCH (2012)
NAViGaTing the Micronome - Using Multiple MicroRNA Prediction Databases to Identify Signalling Pathway-Associated MicroRNAs
Elize A. Shirdel et al.
PLOS ONE (2011)
MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-κB1
Li-Min Guo et al.
FEBS JOURNAL (2009)
Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer
SA Bapat et al.
CANCER RESEARCH (2005)
分享论文
